The digenea parasite opisthorchis felineus: A target for the discovery and development of novel drugs

Infectious Disorders - Drug Targets

Volumn 10, Issue 5, 2010, Pages 385-401

  Mordvinov, Viatcheslav A ^a   Furman, Dagmara P ^a,b  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

^b NOVOSIBIRSK STATE UNIVERSITY   (Russian Federation)

Author keywords

Drug discovery; Eurasia; Flatworm; Opisthorchis felineus; Opisthorchosis; Praziquantel

Indexed keywords

ANTHELMINTIC AGENT; PRAZIQUANTEL;

ARTICLE; BALTIC SEA; CARCINOGENICITY; CLONORCHIASIS; CLONORCHIS SINENSIS; DISEASE COURSE; EUROPE; GENOTOXICITY; HUMAN; LIVER TOXICITY; NONHUMAN; OPISTHORCHIASIS; OPISTHORCHIS; OPISTHORCHIS FELINEUS; OPISTHORCHIS VIVERRINI; RIVER BASIN; SIDE EFFECT; SNAIL; TAXONOMY; TREMATODIASIS; USSR;

EID: 79751516685     PISSN: 18715265     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152610793180858     Document Type: Article

References (163)

1. Zubov, N.A., Shain, A.A. Opisthorchiasis and cancer of the liver among the population of the Khanty-Mansiiskii national district. Vopr. Onkol., 1971, 17(6), 34-39.
2. Shain, A.A. Symptomatology of primary liver cancer. Vopr. Onkol., 1974, 20(9), 50-56.
3. Blokhin, N.N.; Klimenkov, A.A.; Itin, A.V.; Komov, D.V.; Assekritova, I.V. Primary cancer of the liver according to the materials of the Scientific Oncological Center of the AMS USSR. Vestn. Akad. Med. Nauk SSSR, 1978, (5), 3-9.
4. Yablokov, D.D. Opisthorchosis in Man [in Russian]; Tomsk University Press:Tomsk, 1984.
5. Sripa, B. Concerted action is needed to tackle liver fluke infections in Asia. PLoS Negl. Trop. Dis., 2008, 2(5), e232.
6. King, S.; Scholz, T. Trematodes of the family Opisthorchiidae: a minireview. Korean J. Parasitol., 2001, 39(3), 209-221.
7. Bronstein, A.M.; Luchshev, V.I. Hepatic trematode infections: opisthorchiasis, clonorchiasis. Russ. Med. J., 1998, 6, 140-148.
8. Skryabin, K.I.; Petrov, A.M. Animal and Human Trematodes, Nauka:Moscow, 1950, Vol, 4.
9. Sidorov, E.G. Natural Foci of Opisthorchosis [in Russian]; Nauka Kaz. SSR:Alma-Ata, 1983.
10. Romashov, B.V.; Romashov, V.A.; Semenov, V.; Filimonova, L.V. Opisthorchosis in the Upper Don Basin (Voronezh Oblast): The Liver Fluke Fauna, Ecological and Biological Patterns of Circulation and Foci of Opisthorchiases [in Russian]; Voronezh State University:Voronezh, 2005.
11. Tselepatiotis, E.; Mantadakis, E.; Papoulis, S.; Vassalou, E.; Kotsakis, P.; Samonis, G. A case of Opisthorchis felineus infestation in a pilot from Greece. Infection, 2003, 31(6), 430-432.
12. Muller, R. Worms and Human Disease, 2 ed; The London School of Hygiene and Tropical Medicine:UK, 2001.
13. Sripa, B.; Kaewkes, S.; Sithithaworn, P.; Mairiang, E.; Laha, T.; Smout, M.; Pairojkul, C.; Bhudhisawasdi, V.; Tesana, S.; Thinkamrop, B.; Bethony, J.M.; Loukas, A.; Brindley, P.J. Liver fluke induces cholangiocarcinoma. PLoS Med., 2007, 4(7), e201.
14. Sripa, B.; Mairiang, E.; Thinkhamrop, B.; Laha, T.; Kaewkes, S.; Sithithaworn, P.; Tessana, S.; Loukas, A.; Brindley, P.J.; Bethony, J.M. Advanced periductal fibrosis from infection with the carcinogenic human liver fluke Opisthorchis viverrini correlates with elevated levels of interleukin-6. Hepatology, 2009, 50(4), 1273-1281.
15. Andrews, R.H.; Sithithaworn, P.; Petney, T.N. Opisthorchis viverrini: an underestimated parasite in world health. Trends Parasitol., 2008, 24(11), 497-501.
16. Sneader, W. Drug discovery: A History; John Wiley & Sons Ltd:West Sussex, 2005.
17. Trevor, A.J.; Katzung, B.G.; Masters, S.B. Katzung & Trevor's Review of Pharmacology: Examination & Board Review, 8 ed; McGraw-Hill Professional:United States, 2008.
18. Control of foodborne trematode infections. Report of a WHO Study Group. World Health Organ. Tech. Rep. Ser., 1995, 849, 1-157.
19. Rim, H.J. The current pathobiology and chemotherapy of clonorchiasis. Kisaengchunghak Chapchi, 1986, 24 (Suppl), 1-141.
20. Rim, H.J. Clonorchiasis: an update. J. Helminthol., 2005, 79(3), 269-281.
21. Beer, S.A. Biology of Opisthorchosis Invasion Agent [in Russian]; KMK Press:Moscow, 2005.
22. Posokhov, P.S. Clonorchosis in the Amur River Basin [in Russian]; Far East State Medical University:Khabarovsk, 2004.
23. Lun, Z.-R.; Gasser, R.B.; Lai, D.-H.; Li, A.-X.; Zhu, X.-Q.; Yu, X.- B.; Fang, Y.-Y. Clonorchiasis: a key foodborne zoonosis in China. Lancet Infect. Dis., 2005, 5(1), 31-41.
24. Sergiev, V.P.; Beer, S.A. (Eds.) Opisthorchosis. Theory and Practice [in Russian with English Summary]; The USSR Helmintol. Soc.: Moscow, 1989.
25. Chen, M.; Lu, Y.; Hua, X.; Mott, K.E. Progress in assessment of morbidity due to Clonorchis sinensis infection: a review of recent literature. Trop. Dis. Bull., 1994, 91, 7-65.
26. Romagnoli, A. Il Progresso Veterinario, 2002, LVII, 650-654.
27. Karpenko, S.V.; Chechulin, A.I.; Yurlova, N.I.; Serbina, E.A.; Vodyanitskaya, S.N.; Krivopalov, A.V.; Fedorov, K. P. Characteristics of Opisthorchiasis foci in southern west Siberia. Contemp. Probl. Ecol., 2008, 1, 517-521.
28. Bisseru, B. On the genus Opisthorchis R. Blanchard, 1895, with a note on the occurrence of O. geminus (Looss, 1896) in new avian hosts. J. Helminthol., 1957, 31(3), 187-202.
29. Vogel, H. Der Entwicklungszyklus von Opistorchis felineus. Far East Assoc. Trop. Med. (Nanking), 1934, 1, 619-624.
30. Aho, J.M.; Gibbons, J.W.; Esch, G.W. In: Thermal ecology; Esch, G.W.; McFarlane, R.W., Eds.; ERDA Symposium Series:Georgia, 1976, vol. 40, pp. 213-240.
31. Sous, S.M. Influence of environmental factors on the infection rates of fishes and shellfishes by trematodes of the Opisthorchidae family in the Krotovaya Lyaga Lake. Med. Parazitol. (Mosk), 2006 (1), 41-46.
32. Solovykh, G.N.; Kanunikova, E.A. Rivers of the Orenburg Region: maintenance of the life cycle of Opisthorchis felineus. Med. Parazitol. (Mosk), 2007, (3), 15-18.
33. Kaewkes, S. Taxonomy and biology of liver flukes. Acta Trop., 2003, 88(3), 177-186.
34. Erhardt, A.; Germer, W.D.; Hoerning, B. Die Opisthorchosis, hervorgerufen durch den Katzenleberegel Opisthorchis felineus (Riv.); VEB G. Fischer Verlag:Jena, 1962.
35. Braun, M. Die Tierischen Parasiten Des. Menschen; Verlag: Leipzig, 1925.
36. Kotlan, A. Helminthologie:Budapest, 1960.
37. Segovia, J.M.; Torres, J.; Miquel, J. The red fox, Vulpes vulpes L., as a potential reservoir of zoonotic flukes in the Iberian Peninsula. Acta Parasitol., 2002, 47, 163-166.
38. Segovia, J.M.; Torres, J.; Miquel, J. Helminth parasites of the red fox (Vulpes vulpes L., 1758) in the Iberian Peninsula: an ecological study. Acta Parasitol., 2004, 49, 67-79.
39. Oliveira, P.; Pires, M.A.; Rodrigues, P.; Ginja, M.; Pires, M.J.; Pires, I.; Cardoso, L.; Antunes, L.; Rodrigues, M. Opisthorchis felineus in cat: case report. Arq. Bras. Med. Vet. Zootec., 2005, 57(4), 556-558.
40. Schuster, R.; Bonin, J.; Staubach, C.; Heidrich, R. Liver fluke (Opisthorchiidae) findings in red foxes (Vulpes vulpes) in the eastern part of the Federal State Brandenburg, Germany--a contribution to the epidemiology of opisthorchiidosis. Parasitol. Res., 1999, 85(2), 142-146.
41. Schuster, R.; Gregor, B.; Heidrich, J.; Nöckler, K.; Kyule, M.; Wittstatt, U. A sero-epidemiological survey on the occurrence of opisthorchiid liver flukes in red foxes (Vulpes vulpes) in Berlin, Germany. Parasitol. Res., 2003, 90(5), 400-404.
42. Armignacco, O.; Caterini, L.; Marucci, G.; Ferri, F.; Bernardini, G.; Natalini Raponi, G.; Ludovisi, A.; Bossù, T.; Gomez Morales, M.A.; Pozio, E. Human illnesses caused by Opisthorchis felineus flukes, Italy. Emerg. Infect. Dis., 2008, 14(12), 1902-1905.
43. Malakhov, V.V. While Candle Burns. Essays on the History of the Chair of Invertebrate Biology with Moscow State University [in Russian]; KMK Press:Moscow, 2006.
44. Soprunov, F.F. (Ed.). Human Helminthoses: Epidemiology and Control [in Russian]; Meditsina:Moscow, 1985.
45. Kanunikova, E.A.; Solovykh, G.N. Typification of opisthorchiasis foci in the Orenburg Region. Med. Parazitol. (Mosk), 2007 (3), 11-14.
46. Bronshtein, A.M. 2. Opisthorchiasis and diphyllobothriasis morbidity in the native population of the Kyshik settlement, Khanty-Mansi Autonomous Okrug. Med. Parazitol. (Mosk), 1986 (3), 44-48.
47. Bronshtein, A.M.; Uchuatkinn, E.A.; Romanenko, N.A.; Kantsan, S.N.; Veretennikova, N.L. Comprehensive assessment of an opisthorchiasis focus in the Komi-Permiak Autonomous Okrug. Med. Parazitol. (Mosk), 1989 (4), 66-72.
48. Bronshtein, A.M.; Zolotukhin, V.A.; Gitsu, G.A.; Sabgaida, T.P.; Parfenov, S.B. The clinico-epidemiological characteristics of opisthorchiasis foci in the Yamalo-Nenets Autonomous Okrug and the treatment results with praziquantel. Med. Parazitol. (Mosk), 1991(5), 12-16.
49. Mel'nikov, V.I.; Skarednov, N.I. Clinical aspects of acute opisthorchiasis in the nonnative population of the northern Ob region. Med. Parazitol. (Mosk), 1979, 48(5), 12-16.
50. Hou, P.C. The pathology of Clonorchis sinensis infestation of the liver. J. Pathol. Bacteriol., 1955, 70(1), 53-64.
51. Zubov, N.A.; Zubkov, V.G. Hyperplastic changes in the major duodenal papilla in human opisthorchiasis. Arkh. Patol., 1983, 45(1), 34-38.
52. Harinasuta, T.; Riganti, M.; Bunnag, D. Opisthorchis viverrini infection: pathogenesis and clinical features. Arzneimittel- Forschung, 1984, 34(9B), 1167-1169.
53. Hutadilok, N.; Thamavit, W.; Upatham, E.S.; Ruenwongsa, P. Liver procollagen prolyl hydroxylase in Opisthorchis viverrini infected hamsters after praziquantel administration. Mol. Biochem. Parasitol., 1983, 9(4), 289-295.
54. Changbumrung, S.; Ratarasarn, S.; Hongtong, K.; Migasena, P.; Vutikes, S.; Migasena, S. Lipid composition of serum lipoprotein in opisthorchiasis. Ann. Trop. Med. Parasitol., 1988, 82(3), 263-269.
55. Brazhnikova, N.A.; Tskhay, V.F. Constriction of the bile duct in opisthorchiasis [in Russian] Bull. Sib. Med., 2003, 2(4), 58-66.
56. Lim, J.H.; Kim, S.Y.; Park, C.M. Parasitic diseases of the biliary tract. AJR Am. J. Roentgenol., 2007, 188(6), 1596-1603.
57. Lim, J.H.; Mairiang, E.; Ahn, G.H. Biliary parasitic diseases including clonorchiasis, opisthorchiasis and fascioliasis. Abdom. Imaging, 2008, 33(2), 157-165.
58. Kaewpitoon, N.; Kaewpitoon, S.-J.; Pengsaa, P.; Sripa, B. Opisthorchis viverrini: the carcinogenic human liver fluke. World J. Gastroenterol., 2008, 14(5), 666-674.
59. Holzinger, F.; Z'Graggen, K.; Büchler, M.W. Mechanisms of biliary carcinogenesis: a pathogenetic multi-stage cascade towards cholangiocarcinoma. Ann. Oncol., 1999, 10(Suppl 4), 122-126.
60. Gores, G.J. Cholangiocarcinoma: current concepts and insights. Hepatology, 2003, 37(5), 961-969.
61. Pinlaor, S.; Hiraku, Y.; Ma, N.; Yongvanit, P.; Semba, R.; Oikawa, S.; Murata, M.; Sripa, B.; Sithithaworn, P.; Kawanishi, S. Mechanism of NO-mediated oxidative and nitrative DNA damage in hamsters infected with Opisthorchis viverrini: a model of inflammation- mediated carcinogenesis. Nitric Oxide, 2004, 11(2), 175-183.
62. Tischoff, I.; Wittekind, C.; Tannapfel, A. Role of epigenetic alterations in cholangiocarcinoma. J. Hepatobiliary Pancreat. Surg., 2006, 13(4), 274-279.
63. Kim, E.M.; Kim, J.S.; Choi, M.H.; Hong, S.T.; Bae, Y.M. Effects of excretory/secretory products from Clonorchis sinensis and the carcinogen dimethylnitrosamine on the proliferation and cell cycle modulation of human epithelial HEK293T cells. Korean J. Parasitol., 2008, 46(3), 127-132.
64. Kim, Y.J.; Choi, M.H.; Hong, S.T.; Bae, Y.M. Resistance of cholangiocarcinoma cells to parthenolide-induced apoptosis by the excretory- secretory products of Clonorchis sinensis. Parasitol. Res., 2009, 104(5), 1011-1016.
65. Adams, A.M. In: Foodborne Parasites; Ortega, Y.R., Ed.; Springer US, 2006, pp. 161-196.
66. Bronshtein, A.M.; Mironov, S.P.; Silaev, A.V.; Panteleeva, E. Radionuclide and sonographic diagnosis of lesions of the hepatobiliary system in opisthorchiasis. Med. Parazitol. (Mosk), 1989 (5), 13-17.
67. Rana, S.S.; Bhasin, D.K.; Nanda, M.; Singh, K. Parasitic infestations of the biliary tract. Curr. Gastroenterol. Rep., 2007, 9(2), 156-164.
68. Muller, B.; Schmidt, J.; Mehlhorn, H. PCR diagnosis of infections with different species of Opisthorchiidae using a rapid clean-up procedure for stool samples and specific primers. Parasitol. Res., 2007, 100(4), 905-909.
69. Muller, B.; Schmidt, J.; Mehlhorn, H. Sensitive and speciesspecific detection of Clonorchis sinensis by PCR in infected snails and fishes. Parasitol. Res., 2007, 100(4), 911-914.
70. Pauly, A.; Schuster, R.; Steuber, S. Molecular characterization and differentiation of opisthorchiid trematodes of the species Opisthorchis felineus (Rivolta, 1884) and Metorchis bilis (Braun, 1790) using polymerase chain reaction. Parasitol. Res., 2003, 90(5), 409-414.
71. Pauly, A. Molekulare Charakteristik von adulten Trematoden der Familie Opisthorchiidae mittels PCR und RFLP-Analyse; Mensch & Buch Verl:Berlin, 2003.
72. Ribeiro-dos-Santos, G.; Verjovski-Almeida, S.; Leite, L.C.C. Schistosomiasis--a century searching for chemotherapeutic drugs. Parasitol. Res., 2006, 99(5), 505-521.
73. Reich, M.R. Ed. International Strategies for Tropical Disease Treatments: Experiences with Praziquantel, DAP Research Series No. 26, WHO/DAP/CTD/98.5, Action Programme on Essential Drugs; Wld. Hlth. Org.: Geneva, 1998.
74. Cioli, D.; Pica-Mattoccia, L. Praziquantel. Parasitol. Res., 2003, 90(Suppl 1), S3-9.
75. Abdul-Ghani, R.; Loutfy, N.; el-Sahn, A.; Hassan, A. Current chemotherapy arsenal for schistosomiasis mansoni: alternatives and challenges. Parasitol. Res., 2009, 104(5), 955-965.
76. Doenhoff, M.J.; Coles, G.C.; Pica-Mattoccia, L.; Francklow, K.W. In: Antimicrobial Drug Resistance; Mayers, D.L., Ed.; Humana Press:New York, 2009, pp. 629-646.
77. Bunnag, D.; Harinasuta, T. Studies on the chemotherapy of human opisthorchiasis: III. Minimum effective dose of praziquantel. Southeast Asian J. Trop. Med. Public Health, 1981, 12(3), 413-417.
78. Ridtitid, W.; Wongnawa, M.; Mahatthanatrakul, W.; Punyo, J.; Sunbhanich, M. Rifampin markedly decreases plasma concentrations of praziquantel in healthy volunteers. Clin. Pharm. Ther., 2002, 72(5), 505-513.
79. Andrews, P.; Thomas, H.; Pohlke, R.; Seubert, J. Praziquantel. Med. Res. Rev., 1983, 3(2), 147-200.
80. Redman, C.A.; Robertson, A.; Fallon, P.G.; Modha, J.; Kusel, J.R.; Doenhoff, M.J.; Martin, R.J. Praziquantel: an urgent and exciting challenge. Parasitol. Today, 1996, 12(1), 14-20.
81. Ali, B.H. A short review of some pharmacological, therapeutic and toxicological properties of praziquantel in man and animals. Pak. J. Pharm. Sci., 2006, 19(2), 170-175.
82. Doenhoff, M.J.; Cioli, D.; Utzinger, J. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr. Opin. Inf. Dis., 2008, 21(6), 659-667.
83. Ma, C.; Zhang, Q.F.; Tan, Y.B.; Wang, L. Total synthesis of (-)- praziquantel: an anthelmintic drug. J. Chem. Res., 2004, 2004(3), 186-187.
84. Roszkowski, P.; Maurin, J.K.; Czarnockia, Z. Enantioselective synthesis of (R)-(-)-praziquantel (PZQ). Tetrahedron: Asymmetry, 2006, 17, 1415-1419.
85. Ridtitid, W.; Ratsamemonthon, K.; Mahatthanatrakul, W.; Wongnawa, M. Pharmacokinetic interaction between ketoconazole and praziquantel in healthy volunteers. J. Clin. Pharm. Ther., 2007, 32(6), 585-593.
86. Castro, N.; Jung, H.; Medina, R.; González-Esquivel, D.; Lopez, M.; Sotelo, J. Interaction between grapefruit juice and praziquantel in humans. Antimicrob. Agents Chemother., 2002, 46(5), 1614-1616.
87. el Guiniady, M.A.; el Touny, M.A.; Abdel-Bary, M.A.; Abdel- Fatah, S.A.; Metwally, A. Clinical and pharmacokinetic study of praziquantel in Egyptian schistosomiasis patients with and without liver cell failure. Am. J. Trop. Med. Hyg., 1994, 51(6), 809-818.
88. Omar, A.; Elmesallamy Gel, S.; Eassa, S. Comparative study of the hepatotoxic, genotoxic and carcinogenic effects of praziquantel distocide & the natural myrrh extract Mirazid on adult male albino rats. J. Egypt Soc. Parasitol., 2005, 35(1), 313-329.
89. Olds, G.R. Administration of praziquantel to pregnant and lactating women. Acta Trop., 2003, 86(2-3), 185-195.
90. Caffrey, C.R. Chemotherapy of schistosomiasis: present and future. Curr. Opin. Chem. Biol., 2007, 11(4), 433-439.
91. Keiser, J.; Utzinger, J. Advances in the discovery and development of novel trematocidal drugs. Expert Opin. Drug Discov., 2007, 2(Suppl 1), S9-S23.
92. Hong, S.T.; Rim, H.J.; Min, D.Y.; Li, X.; Xu, J.; Feng, Z.; Lee, S.H. Control of clonorchiasis by repeated treatments with praziquantel. Korean J. Parasitol., 2001, 39(4), 285-292.
93. Matthaiou, D.K.; Panos, G.; Adamidi, E.S.; Falagas, M.E. Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials. PLoS Negl. Trop. Dis., 2008, 2(3), e194.
94. Greenberg, R.M. Are Ca2+ channels targets of praziquantel action? Int. J. Parasitol., 2005, 35(1), 1-9.
95. Greenberg, R. M. Molecular target of the antischistosomal drug praziquantel. Future Med., 2007, 2(3), 265-268.
96. Chaiworaporn, R.; Maneerat, Y.; Rojekittikhun, W.; Ramasoota, P.; Janecharut, T.; Matsuda, H.; Kitikoon, V. Therapeutic effect of subcurative dose praziquantel on Schistosoma mansoni infected mice and resistance to challenge infection after treatment. Southeast Asian J. Trop. Med. Public Health, 2005, 36(4), 846-852.
97. Abdulla, M.-H.; Lim, K.-C.; Sajid, M.; McKerrow, J.H.; Caffrey, C.R. Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor. PLoS Med., 2007, 4(1), e14.
98. Cioli, D.; Pica-Mattoccia, L. In: Schistosomosis (World Class Parasites); Secor, W.E.; Colley, D.G., Ed.; Springer:New York, 2004, pp. 191-206.
99. Botros, S.; William, S.; Hammam, O.; Zídek, Z.; Holý A. Activity of 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine against Schistosomiasis mansoni in mice. Antimicrob. Agents Chemother., 2003, 47(12), 3853-3858.
100. King, C.H.; Muchiri, E.M.; Ouma, J.H. Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya. Emerg. Infect. Dis., 2000, 6(6), 585-594.
101. Alonso, D.; Munoz, J.; Gascon, J.; Valls, M.E.; Corachan, M. Failure of standard treatment with praziquantel in two returned travelers with Schistosoma haematobium infection. Am. J. Trop. Med. Hyg., 2006, 74(2), 342-344.
102. Sangster, N.C.; Maitland, G.N.; Geerts, S.; Decuypere, S.; Dujardin, J.; Upcroft, J.A.; Upcroft, P.; Duraisingh, D.L. In: Antimicrobial Drug Resistance: Clinical and Epidemiological Aspects, Volume 2 (Infectious Disease); Mayers, D.L., Ed.; Humana Press:New York, 2009, pp. 1201-1225.
103. Xu, D.; Curtis, J.; Feng, Z.; Minchella, D.J. On the role of schistosome mating structure in the maintenance of drug-resistant strains. Bull. Math. Biol., 2006, 68(2), 209-229.
104. Mehlhorn, H.; Becker, B.; Andrews, P.; Thomas, H.; Frenkel, J.K. In vivo and in vitro experiments on the effects of praziquantel on Schistosoma mansoni. A light and electron microscopic study. Arzneimittel-Forschung, 1981, 31(3a), 544-554.
105. Shen, C.; Kim, J.; Lee, J.K.; Bae, Y.M.; Choi, M.H.; Oh, J.K.; Lim, M.K.; Shin, H.R.; Hong, S.T. Collection of Clonorchis sinensis adult worms from infected humans after praziquantel treatment. Korean J. Parasitol., 2007, 45(2), 149-152.
106. Brindley, P.J.; Sher, A. The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response. J. Immunol., 1987, 139(1), 215-220.
107. Doenhoff, M.J.; Sabah, A.A.; Fletcher, C.; Webbe, G.; Bain, J. Evidence for an immune-dependent action of praziquantel on Schistosoma mansoni in mice. Trans. R. Soc. Trop. Med. Hyg., 1987, 81(6), 947-951.
108. Doenhoff, M.J.; Modha, J.; Lambertucci, J.R. Anti-schistosome chemotherapy enhanced by antibodies specific for a parasite esterase. Immunology, 1988, 65(4), 507-510.
109. Jeziorski, M.C.; Greenberg, R.M. Voltage-gated calcium channel subunits from platyhelminths: potential role in praziquantel action. Int. J. Parasitol., 2006, 36(6), 625-632.
110. Pica-Mattoccia, L.; Valle, C.; Basso, A.; Troiani, A.R.; Vigorosi, F.; Liberti, P.; Festucci, A.; Cioli, D. Cytochalasin D abolishes the schistosomicidal activity of praziquantel. Exp. Parasitol., 2007, 115(4), 344-351.
111. Pica-Mattoccia, L.; Orsini, T.; Basso, A.; Festucci, A.; Liberti, P.; Guidi, A.; Marcatto-Maggi, A.-L.; Nobre-Santana, S.; Troiani, A.- R.; Cioli, D.; Valle, C. Schistosoma mansoni: lack of correlation between praziquantel-induced intra-worm calcium influx and parasite death. Exp. Parasitol., 2008, 119(3), 332-335.
112. Nogi, T.; Zhang, D.; Chan, J.D.; Marchant, J.S. A novel biological activity of praziquantel requiring voltage-operated Ca2+ channel beta subunits: subversion of flatworm regenerative polarity. PLoS Negl. Trop. Dis., 2009, 3(6), e464.
113. Kohn, A.B.; Anderson, P.A.; Roberts-Misterly, J.M.; Greenberg, R.M. Schistosome calcium channel beta subunits. Unusual modulatory effects and potential role in the action of the antischistosomal drug praziquantel. J. Biol. Chem., 2001, 276(40), 36873-36876.
114. Kusel, J.R.; Oliveira, F.A.; Todd, M.; Ronketti, F.; Lima, S.F.; Mattos, A.C.A.; Reis, K.T.; Coelho, P.M.Z.; Thornhill, J.A.; Ribeiro, F. The effects of drugs, ions, and poly-l-lysine on the excretory system of Schistosoma mansoni. Mem. Inst. Oswaldo Cruz, 2006, 101(Suppl 1), 293-298.
115. Sluis-Cremer, N.; Naidoo, N.N.; Kaplan, W.H.; Manoharan, T.H.; Fahl, W.E.; Dirr, H.W. Determination of a binding site for a nonsubstrate ligand in mammalian cytosolic glutathione S-transferases by means of fluorescence-resonance energy transfer. Eur. J. Biochem., 1996, 241, 484-488.
116. Sheehan, D.; Meade, G.; Foley, V.M.; Dowd, C.A. Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem. J., 2001, 360(Pt 1), 1-16.
117. Gnanasekar, M.; Salunkhe, A.M.; Mallia, A.K.; He, Y.X.; Kalyanasundaram, R. Praziquantel affects the regulatory myosin light chain of Schistosoma mansoni. Antimicrob. Agents Chemother., 2009, 53(3), 1054-1060.
118. Fitzpatrick, J.M.; Hirai, Y.; Hirai, H.; Hoffmann, K.F. Schistosome egg production is dependent upon the activities of two developmentally regulated tyrosinases. FASEB J., 2007, 21(3), 823-835.
119. Curtis, J.; Minchella, D.J. Schistosome population genetic structure: when clumping worms is not just splitting hairs. Parasitol. Today, 2000, 16(2), 68-71.
120. Mahajan, S.; Atkins, W.M. The chemistry and biology of inhibitors and pro-drugs targeted to glutathione S-transferases. Cell. Mol. Life Sci., 2005, 62(11), 1221-1233.
121. Liu, F.; Lu, J.; Hu, W.; Wang, S.Y.; Cui, S.J.; Chi, M.; Yan, Q.; Wang, X.R.; Song, H.D.; Xu, X.N.; Wang, J.J.; Zhang, X.L.; Zhang, X.; Wang, Z.Q.; Xue, C.L.; Brindley, P.J.; McManus, D.P.; Yang, P.Y.; Feng, Z.; Chen, Z.; Han, Z.G. New perspectives on host-parasite interplay by comparative transcriptomic and proteomic analyses of Schistosoma japonicum. PLoS Pathog., 2006, 2(4), e29.
122. Maruyama, H.; Nawa, Y. In: Food-Borne Parasitic Zoonoses: Fish and Plant-Borne Parasites (World Class Parasites); Murrell, K.D.; Fried, B., Ed.; Springer:New York, 2007, pp. 337-381.
123. McManus, D.P.; Loukas, A. Current status of vaccines for schistosomiasis. Clin. Microb. Rev., 2008, 21(1), 225-242.
124. Jiz, M.; Wu, H.-W.; Meng, R.; Pond-Tor, S.; Reynolds, M.; Friedman, J.F.; Olveda, R.; Acosta, L.; Kurtis, J.D. Pilot-scale production and characterization of paramyosin, a vaccine candidate for schistosomiasis japonica. Infect. Immune, 2008, 76(7), 3164-3169.
125. Gobert, G.N.; Moertel, L.; Brindley, P.J.; McManus, D.P. Developmental gene expression profiles of the human pathogen Schistosoma japonicum. BMC Genomics, 2009, 10, 128.
126. Arijo, A.G.; Qureshi, T.A.; Pathan, Z.A. A studies on chemical control of S. mansoni intermediate host. Pak. J. Biol. Sci., 2007, 10(15), 2606-2608.
127. Dai, J.R.; Wang, W.; Liang, Y.S.; Li, H.J.; Guan, X.H.; Zhu, Y.C. A novel molluscicidal formulation of niclosamide. Parasitol. Res., 2008, 103(2), 405-412.
128. Arijo, A.G.; Doenhoff, M.J. Establishment of a Gene Pool Strain of Biomphalaria glabrata Snail Host of Schistosoma mansoni. Pak. J. Biol. Sci., 2000, 3(12), 2176-2178.
129. Arijo, A.G.; Doenhoff, M.J.; Soomro, N.M.; Rajput, Z.I. Hostparasite relationship of S. mansoni and B. glabrata. Pak. J. Biol. Sci., 2007, 10(24), 4399-4405.
130. Beer, S.A. Perspectives of the control of Opisthorchis invasion by the method of treating the molluskan population. Parazitologiia, 1976, 10(6), 473-481.
131. Renslo, A.R.; McKerrow, J.H. Drug discovery and development for neglected parasitic diseases. Nat. Chem. Biol., 2006, 2(12), 701-710.
132. Khandelwal, N.; Shaw, J.; Jain, M.K. Biliary parasites: diagnostic and therapeutic strategies. Curr. Treat. Options Gastroenterol., 2008, 11(2), 85-95.
133. Woods, D.J.; Williams, T.M. The challenges of developing novel antiparasitic drugs. Invert. Neurosci., 2007, 7(4), 245-250.
134. Eckstein, J.: ISOA/ARF Drug Development Tutorial. www.alzforum.org/drg/tut/ISOATutorial.pdf (Accessed December 31, 2009).
135. Nwaka, S.; Hudson, A. Innovative lead discovery strategies for tropical diseases. Nat. Rev. Drug Discov., 2006, 5(11), 941-955.
136. Drab, A.I.; Nurmukhametova, K.A.; Pak, R.N.; Adekenov, S.M. Antiopisthorchotic action of Saussurea salsa extract. Pharm. Chem. J., 2005, 39(8), 425-427.
137. Overington, J.P.; Al-Lazikani, B.; Hopkins, A.L. How many drug targets are there? Nat. Rev. Drug Discov., 2006, 5(12), 993-996.
138. Laha, T.; Pinlaor, P.; Mulvenna, J.; Sripa, B.; Sripa, M.; Smout, M.J.; Gasser, R.B.; Brindley, P.J.; Loukas, A. Gene discovery for the carcinogenic human liver fluke, Opisthorchis viverrini. BMC Genomics, 2007, 8, 189.
139. Caffrey, C.R.; Rohwer, A.; Oellien, F.; Marhöfer, R.J.; Braschi, S.; Oliveira, G.; McKerrow, J.H.; Selzer, P.M. A comparative chemogenomics strategy to predict potential drug targets in the metazoan pathogen, Schistosoma mansoni. PloS One, 2009, 4(2), e4413.
140. Kinnings, S.L.; Liu, N.; Buchmeier, N.; Tonge, P.J.; Xie, L.; Bourne, P.E. Drug discovery using chemical systems biology: repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosis. PLoS Comput. Biol., 2009, 5 (7), e1000423.
141. Sayed, A.A.; Simeonov, A.; Thomas, C.J.; Inglese, J.; Austin, C.P.; Williams, D.L. Identification of oxadiazoles as new drug leads for the control of schistosomiasis. Nat. Med., 2008, 14(4), 407-412.
142. Pinlaor, P.; Kaewpitoon, N.; Laha, T.; Sripa, B.; Kaewkes, S.; Morales, M.E.; Mann, V.H.; Parriott, S.K.; Suttiprapa, S.; Robinson, M.W.; To, J.; Dalton, J.P.; Loukas, A.; Brindley, P.J. Cathepsin F cysteine protease of the human liver fluke, Opisthorchis viverrini. PLoS Negl. Trop. Dis., 2009, 3(3), e398.
143. Gelb, M.H.; Van Voorhis, W.C.; Buckner, F.S.; Yokoyama, K.; Eastman, R.; Carpenter, E.P.; Panethymitaki, C.; Brown, K.A.; Smith, D.F. Protein farnesyl and N-myristoyl transferases: piggyback medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics. Mol. Biochem. Parasitol., 2003, 126(2), 155-163.
144. Eastman, R.T.; Buckner, F.S.; Yokoyama, K.; Gelb, M.H.; Van Voorhis, W.C. Thematic review series: lipid posttranslational modifications. Fighting parasitic disease by blocking protein farnesylation. J. Lipid Res., 2006, 47(2), 233-240.
145. Gelb, M.H. Drug discovery for malaria: a very challenging and timely endeavor. Curr. Opin. Chem. Biol., 2007, 11(4), 440-445.
146. Kraus, J.M.; Verlinde, C.L.M.J.; Karimi, M.; Lepesheva, G.I.; Gelb, M.H.; Buckner, F.S. Rational modification of a candidate cancer drug for use against Chagas disease. J. Med. Chem., 2009, 52(6), 1639-1647.
147. Utzinger, J.; Keiser, J.; Shuhua, X.; Tanner, M.; Singer, B.H. Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrob. Agents Chemother., 2003, 47(5), 1487-1495.
148. Utzinger, J.; Xiao, S.-H.; Tanner, M.; Keiser, J. Artemisinins for schistosomiasis and beyond. Curr. Opin. Investig. Drugs, 2007, 8(2), 105-116.
149. Keiser, J.; Shu-Hua, X.; Tanner, M.; Utzinger, J. Artesunate and artemether are effective fasciolicides in the rat model and in vitro. J. Antimicrob. Chemother., 2006, 57(6), 1139-1145.
150. Keiser, J.; Shu-Hua, X.; Chollet, J.; Tanner, M.; Utzinger, J. Evaluation of the in vivo activity of tribendimidine against Schistosoma mansoni, Fasciola hepatica, Clonorchis sinensis, and Opisthorchis viverrini. Antimicrob. Agents Chemother., 2007, 51(3), 1096-1098.
151. Keiser, J.; Utzinger, J.; Xiao, S.-H.; Odermatt, P.; Tesana, S. Opisthorchis viverrini: efficacy and tegumental alterations following administration of tribendimidine in vivo and in vitro. Parasitol. Res., 2008, 102(4), 771-776.
152. Xiao, S.H.; Keiser, J.; Xue, J.; Tanner, M.; Morson, G.; Utzinger, J. Effect of single-dose oral artemether and tribendimidine on the tegument of adult Clonorchis sinensis in rats. Parasitol. Res., 2009, 104(3), 533-541.
153. Abdel-Aziz, M.M.; Abbas, A.T.; Elbakry, K.A.; Toson, E.A.; El- Sherbiny, M. Immune response on mice infected with Schistosoma mansoni and treated with Mirrh. J. Med. Sci., 2006, 6(5), 858-861.
154. Barakat, R.; Elmorshedy, H.; Fenwick, A. Efficacy of myrrh in the treatment of human Schistosomiasis mansoni. Am. J. Trop. Med. Hyg., 2005, 73(2), 365-367.
155. Kaliuzhina, M.I.; Kaliuzhin, O.V.; Kaliuzhin, V.V.; Shkalev, M.V. Residual Opisthorchosis [in Russian]; Publishing house of RAMS:Moscow, 2004.
156. Olds, G.R.; Dasarathy, S. Recent Advances in Schistosomiasis. Curr. Infect. Dis. Rep., 2001, 3(1), 59-67.
157. Nascimento, E.; Leão, I.C.; Pereira, V.R.A.; Gomes, Y.M.; Chikhlikar, P.; August, T.; Marques, E.; Lucena-Silva, N. Protective immunity of single and multi-antigen DNA vaccines against schistosomiasis. Mem. Inst. Oswaldo Cruz, 2002, 97(Suppl 1), 105-109.
158. Nara, T.; Iizumi, K.; Ohmae, H.; Sy, O.S.; Tsubota, S.; Inaba, Y.; Tsubouchi, A.; Tanabe, M.; Kojima, S.; Aoki, T. Antibody isotype responses to paramyosin, a vaccine candidate for schistosomiasis, and their correlations with resistance and fibrosis in patients infected with Schistosoma japonicum in Leyte, The Philippines. Am. J. Trop. Med. Hyg., 2007, 76(2), 384-391.
159. Siddiqui, A.A.; Ahmad, G.; Damian, R.T.; Kennedy, R.C. Experimental vaccines in animal models for schistosomiasis. Parasitol. Res., 2008, 102(5), 825-833.
160. Cardoso, F.C.; Macedo, G.C.; Gava, E.; Kitten, G.T.; Mati, V.L.; de Melo, A.L.; Caliari, M.V.; Almeida, G.T.; Venancio, T.M.; Verjovski- Almeida, S.; Oliveira, S.C. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection. PLoS Negl. Trop. Dis., 2008, 2(10), e308.
161. Choi, D.; Hong, S.T. Imaging diagnosis of clonorchiasis. Korean J. Parasitol., 2007, 45(2), 77-85.
162. Choi, M.-H.; Ryu, J.-S.; Lee, M.; Li, S.; Chung, B.-S.; Chai, J.-Y.; Sithithaworn, P.; Tesana, S.; Hong, S.-T. Specific and common antigens of Clonorchis sinensis and Opisthorchis viverrini (Opisthorchidae, Trematoda). Korean J. Parasitol., 2003, 41(3), 155-163.
163. Lee, M.; Chung, Y.B.; Lee, S.K.; Chung, B.S.; Li, S.; Choi, M.H.; Hong, S.T. The identification of a Clonorchis sinensis gene encoding an antigenic egg protein. Parasitol. Res., 2005, 95(3), 224-226.